Literature DB >> 1974416

Effect of alcohol intake on human apolipoprotein A-I-containing lipoprotein subfractions.

P Puchois1, N Ghalim, G Zylberberg, P Fievet, C Demarquilly, J C Fruchart.   

Abstract

High-density lipoprotein comprises two main types of lipoprotein particles: (1) those that contain apolipoproteins A-I and A-II, designated LpA-I:A-II, and (2) those that contain apolipoprotein A-I but not apolipoprotein A-II, designated LpA-I. Both have been extensively studied and are believed to represent distinct metabolic entities that may confer differing protection against coronary artery disease risk. We have previously suggested that LpA-I might represent the antiatherogenic effect, which has been ascribed mainly to its effect on high-density lipoprotein cholesterol; we set out to investigate, in 344 men, the relation between LpA-I:A-II and LpA-I levels and alcohol consumption. As the alcohol intake rose, LpA-I:A-II levels increased, while LpA-I levels fell. On the assumption that LpA-I is the antiatherogenic fraction of high-density lipoprotein, the putative protective action of alcohol consumption against coronary artery disease should be reconsidered.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974416

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  6 in total

1.  Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors.

Authors:  E B Rimm; P Williams; K Fosher; M Criqui; M J Stampfer
Journal:  BMJ       Date:  1999-12-11

2.  Heterogeneity of high-density lipoprotein particles and insulin output during oral glucose tolerance test in men with coronary artery disease.

Authors:  J Iwanejko; M Kwaśniak; I Wybrańska; J Hartwich; I Guevara; A Zdzienicka; O Kruszelnicka-Kwiatkowska; W Piwowarska; B Miszczuk-Jamska; A Dembińska-Kieć
Journal:  Acta Diabetol       Date:  1996-03       Impact factor: 4.280

3.  Limited discriminant value of lipoprotein AI, lipoprotein Lp(a) and other lipoprotein particles in patients with and without early onset ischaemic heart disease.

Authors:  D T Vallance; H A Staunton; A F Winder
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

4.  Moderate alcohol consumption and lipoprotein subfractions: a systematic review of intervention and observational studies.

Authors:  Trine L Wilkens; Kaare Tranæs; Jane N Eriksen; Lars O Dragsted
Journal:  Nutr Rev       Date:  2022-04-08       Impact factor: 6.846

5.  ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator.

Authors:  Toshimi Kido; Kazuo Kondo; Hideaki Kurata; Yoko Fujiwara; Takeyoshi Urata; Hiroshige Itakura; Shinji Yokoyama
Journal:  Lipids Health Dis       Date:  2017-11-29       Impact factor: 3.876

6.  Bioinformatic Analysis of Plasma Apolipoproteins A-I and A-II Revealed Unique Features of A-I/A-II HDL Particles in Human Plasma.

Authors:  Toshimi Kido; Hideaki Kurata; Kazuo Kondo; Hiroshige Itakura; Mitsuyo Okazaki; Takeyoshi Urata; Shinji Yokoyama
Journal:  Sci Rep       Date:  2016-08-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.